Managing the risk of nosocomial transmission of prion diseases

Purpose of review Prion diseases such as Creutzfeldt-Jakob disease represent a unique infection control problem because prions exhibit an unusual resistance to conventional chemical and physical decontamination methods. This paper reviews the recent literature and provides recommendations for the prevention of nosocomial transmission of prion agents. Recent findings Recommendations to prevent the cross-transmission of infection from medical devices potentially contaminated with prions have been based primarily on prion inactivation studies. Newer recommendations consider inactivation data, but also use epidemiological studies of prion transmission, the infectivity of human tissues, and the efficacy of removing microbes by cleaning. Prion-specific disinfection/sterilization is required in only limited settings. Healthcare workers are not at risk of acquiring transmissible spongiform encephalopathies. Blood or blood products have not been demonstrated to be vehicles for transmission. Summary On the basis of scientific data, only critical (e.g. surgical instruments) and semicritical devices contaminated with high-risk tissue (i.e. brain, spinal cord, eye) from high-risk patients (e.g. with known or suspected Creutzfeldt-Jakob disease) require special treatment.

[1]  S. Oliver,et al.  Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. , 2004, Foodborne pathogens and disease.

[2]  W. Kirkpatrick,et al.  Pharyngoplasty and the risk of variant CJD transmission. , 2001, British journal of plastic surgery.

[3]  C. Masters,et al.  Gerstmann–Sträussler–Scheinker syndrome,fatal familial insomnia, and kuru: a review ofthese less common human transmissiblespongiform encephalopathies , 2001, Journal of Clinical Neuroscience.

[4]  J. Bagg,et al.  Cross infection control: Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob Disease in UK general dental practice , 2001, British Dental Journal.

[5]  J. Ironside,et al.  Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues , 2001, The Lancet.

[6]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[7]  M. Coulthart,et al.  Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[8]  J. Ironside,et al.  Use of 14–3–3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[9]  S. Prusiner,et al.  Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.

[10]  J. Sugar,et al.  Eye banking and screening for Creutzfeldt-Jakob disease. , 2001, Archives of ophthalmology.

[11]  W A Rutala,et al.  Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  L. Schonberger,et al.  Creutzfeldt–Jakob disease after receipt of a previously unimplicated brand of dura mater graft , 2001, Neurology.

[13]  Paul Brown.  Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease , 2001, BMJ : British Medical Journal.

[14]  J. Hauw,et al.  Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt– Jakob disease: Implications for human health , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. McShane,et al.  Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2000, Neurology.

[16]  P. Minor,et al.  Vaccines and variant CJD. , 2000, Vaccine.

[17]  P. Brown.  BSE and transmission through blood , 2000, The Lancet.

[18]  M. Painter.  Variant Creutzfeldt Jakob Disease. , 2000, The Journal of infection.

[19]  C. Farrington,et al.  Incidence of variant Creutzfeldt-Jakob disease in the UK , 2000, The Lancet.

[20]  Herbert Budka.  Prions and transfusion medicine. , 2000, Vox sanguinis.

[21]  K. Wilson,et al.  Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies , 2000, BMJ : British Medical Journal.

[22]  R. Buckley,et al.  CJD and the eye , 2000, Eye.

[23]  M. Haltia,et al.  Human prion diseases , 2000, Neurobiology of Aging.

[24]  M. Haltia,et al.  Human prion diseases , 2000, Annals of medicine.

[25]  John Collinge,et al.  Variant Creutzfeldt-Jakob disease , 1999, The Lancet.

[26]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[27]  C. Gibbs,et al.  Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. , 1998, The New England journal of medicine.

[28]  M. Esiri,et al.  Retrospective Neuropathological Review of Prion Disease in UK Haemophilic Patients , 1998, Thrombosis and Haemostasis.

[29]  S. DeArmond,et al.  Surveillance for Creutzfeldt‐Jakob disease among persons with hemophilia , 1998, Transfusion.

[30]  J. Zajicek,et al.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease , 1998, The Lancet.

[31]  T. Iwaki,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[32]  DavidJ. Evans,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[33]  N. Cashman,et al.  Is Creutzfeldt-Jakob disease transmitted in blood? , 1997, Emerging infectious diseases.

[34]  R. Bradley,et al.  BSE: a decade on-part 2 , 1997, The Lancet.

[35]  Paul Brown,et al.  Bovine spongiform encephalopathy , 1990, Veterinary Record.

[36]  S. Netesov,et al.  Emerging infectious diseases in Russia, 1990-1999. , 2001, Emerging infectious diseases.

[37]  P. Derfler,et al.  The United States Department of Agriculture , 1872, Nature.